Iris E. Eder

Innsbruck Medical University — Austria

Medicine · Health Sciences

31h-index3.7kcitations138works5.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(75), Estrogen and related hormone effects(29), Hormonal and reproductive studies(17), Cancer, Lipids, and Metabolism(17), Cancer, Hypoxia, and Metabolism(9)

Publications138 total

An NMR-Based Metabolic Signature to Identify Clinically Significant Prostate Cancer in Patients Undergoing Biopsy
The Journal of Clinical Endocrinology & Metabolism·2024· 2 citedOpen Access
MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate Cancer
Endocrinology·2024· 13 citedOpen Access
Glycoprofiling of proteins as prostate cancer biomarkers: A multinational population study
PLoS ONE·2024· 6 citedOpen Access
NMR-based metabolomics discriminate between prostate biopsy-positive and biopsy-negative patients suspicious for prostate cancer
European Urology·2024Open Access
Impact of familiarity with the format of the exam on performance in the OSCE of undergraduate medical students – an interventional study
BMC Medical Education·2024· 6 citedOpen Access
MED12 promotes Prostate Cancer (PCa) cell proliferation through the Androgen Receptor (AR) signalling
European Urology Open Science·2023Open Access
Impact of familiarity with the format of the exam on performance in the OSCE of 5th undergraduate medical students – an interventional study
Research Square (Research Square)·2023Open Access
Glycoprofiling of proteins as prostate cancer biomarkers: a multinational population study
2023Open Access
Table S1 from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
2023Open Access
Figure S4 from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
2023Open Access
Figure S3 from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
2023Open Access
Figure S5 from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
2023Open Access
Figure S7 from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
2023Open Access
Figure S1 from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
2023· 1 citedOpen Access
Figure S11 from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
2023Open Access
Figure S10 from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
2023Open Access
Figure S8 from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
2023Open Access
Figure S6 from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
2023Open Access
Data from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
2023Open Access
Suppl Figure legends from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Helmut Klocker(44), Zoran Čulig(18), Georg Bartsch(14), Alfred Hobisch(9), Georg Schäfer(8), Thomas Pütz(7), Georg Bartsch(7), Martin Puhr(7), Isabel Heidegger(7), Hannes Neuwirt(7), Reinhold Ramoner(6), Petra Hååg(6), Jasmin Bektić(6), Claudia Nessler‐Menardi(5), Martin Thurnher(5), A Hittmair(4), G. Bartsch(4), Christian Ploner(4), Florian Handle(4), Natalie Sampson(4)